Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023

The treatment of proliferative diabetic retinopathy (PDR) has evolved significantly since the initial use of panretinal photocoagulation as a treatment in the 1950s. Vascular endothelial growth factor inhibitors have provided an effective alternative without the risk of peripheral vision loss. Despi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arevalo, J. Fernando, Beatson, Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111833/
https://www.ncbi.nlm.nih.gov/pubmed/37072797
http://dx.doi.org/10.1186/s40942-023-00467-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111833/
https://www.ncbi.nlm.nih.gov/pubmed/37072797
http://dx.doi.org/10.1186/s40942-023-00467-8

Ejemplares similares